A medicine with approval
For semaglutide (Ozempic, Wegovy), the Food and Drug Administration’s approval is on record as of September 26, 2026.
With semaglutide (Wegovy), weight reduction and keeping weight off are approved uses alongside diet and activity changes, as of September 26, 2026.
That agency’s name gets shortened to FDA. Ask what the medicine would be used for in your care.
Source note B ↘A medicine made to order
Compounding refers to made-to-order medicine preparation, often done by a pharmacist.
The September 26, 2026 check records compounded medicines as having no FDA approval.
Before sale, a compounded medicine gets no FDA review of how well it works or of its quality and safety.
When approved drugs leave your medical need unmet or are unavailable ready-made, compounding may help, according to the September 26, 2026 check.
Legal limits on copying medicines already sold still apply, as of September 26, 2026.
An exception may apply when whoever writes your prescription decides the change makes a big difference for you as an individual patient.
A price cut alone does not meet that test.
Source note C ↘A research label
In the September 26, 2026 check, FDA cautions that research-labeled weight-loss drugs offered for human use may be harmful and have unknown quality.
Keep products labeled for research out of your search for medical care. A product label cannot tell you what treatment you need or arrange later care.
Source note D ↘